1 ANNEX, Decision_act (EU) 2012/68

In forcesince 3 Feb 2012

Decision 2008/911/EC is amended as follows:

(1)

in Annex I, the following substance is inserted after Thymus vulgaris L., Thymus zygis Loefl. ex L., aetheroleum:

‘Vitis vinifera L., folium’

(2)

in Annex II, the following is inserted after the entry on Thymus vulgaris L., Thymus zygis Loefl. ex L.:

Vitis vinifera L.

Vitaceae

Grapevine leaf [The material complies with the monograph of the Pharmacopée Française X., 1996.’]

BG (bălgarski): лоза, лист

CS (čeština): Červený list vinné révy

DA (dansk): Vinblad

DE (Deutsch): Rote Weinrebenblätter

EL (elliniká): Φύλλο Αμπέλου

EN (English): Grapevine leaf

ES (español): Vid, hoja de

ET (eesti keel): Viinapuu lehed

FI (suomi): Aitoviiniköynnös, lehti

FR (français): Feuille de vigne rouge

HU (magyar): Bortermő szőlő levél

IT (italiano): Vite, foglia

LT (lietuvių kalba): Tikrųjų vynmedžių lapai

LV (latviešu valoda): Īstā vīnkoka lapas

MT (malti): Werqa tad-dielja

NL (nederlands): Wijnstokblad

PL (polski): Liść winorośli właściwej

PT (português): Folha de videira

RO (română): Frunze de viță-de-vie

SK (slovenčina): List viniča

SL (slovenščina): List vinske trte

SV (svenska): Blad från vinranka

IS (íslenska): Vínviðarlauf

NO (norsk): Rød vinranke, blad

Soft extract (2.5-4:1; extraction solvent water)

Not applicable

Traditional herbal medicinal product to relieve symptoms of discomfort and heaviness of legs related to minor venous circulatory disturbances.

The product is a traditional herbal medicinal product for use in specified indication exclusively based upon long-standing use.

European

Please see “Specified posology”.

Soft extract (2.5-4:1; extraction solvent water) in a cream base (10 g contain 282 mg soft extract).

Apply a thin layer on the affected area 1-3 times daily.

The use in children and adolescents under 18 years of age is not recommended (see section “Special warnings and precautions for use”).

Cutaneous use.

The recommended duration of use is 4 weeks.

If the symptoms persist longer than 2 weeks during the use of the medicinal product, a doctor or a qualified health care practitioner should be consulted.

Hypersensitivity to the active substance.

If there is inflammation of the skin, thrombophlebitis or subcutaneous induration, severe pain, ulcers, sudden swelling of one or both legs, cardiac or renal insufficiency, a doctor should be consulted.

The product should not be used on broken skin, around the eyes or on mucous membranes.

In the absence of sufficient safety data, the use in children and adolescents below 18 years of age is not recommended.

None reported.

Safety during pregnancy and lactation has not been established. In the absence of sufficient data, the use during pregnancy and lactation is not recommended.

No studies on the effect on the ability to drive and use machines have been performed.

Contact allergy and/or hypersensitivity reactions of the skin (itching and erythema, urticaria) have been reported. The frequency is not known.

If other adverse reactions not mentioned above occur, a doctor or a qualified health care practitioner should be consulted.

No case of overdose has been reported.

Not applicable.

Not applicable.